U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home

Vaccines, Blood & Biologics

Topic Paragraphs
COVID-19

Featured

Coronavirus (COVID-19) | CBER-Regulated Biologics

SPOTLIGHT

CBER’s Document Control Center (DCC) will not process any submissions received by mail or courier including submissions provided on paper and electronic media (e.g., CDs, USB drives) until further notice. Submissions may be sent through the Electronic Submission Gateway or in some cases by e-mail. Please see the Letter to CBER Sponsors, Applicants and Regulated Entities.

NAVIGATE THE VACCINES, BLOOD & BIOLOGICS SECTION

Allergenics

Allergen Extracts, Allergen Patch Tests, Antigen Skin Test

Vaccines

Vaccines for Use in Children and Adults, Tuberculin Testing

Safety & Availability

Recalls, Shortages, Biological Product Deviation Reporting, Adverse Event Reporting, HIV Home Test Kits

Science & Research

Research by FDA Staff to Evaluate and Enhance the Safety of Biologic Products

News & Events

Latest news and event information from the Center for Biologics and Evaluation at FDA

Center

Recently Published Guidances

Recently published Biologics-related Guidances

Popular Content

notebook, pen, test tubes, and a beaker

Products & Establishments
Recall stamp

Recalls
Make yourself heard by raising your hand

Advisory Committees
Center

CBER Press Announcements

Biologics related Press Announcements

Evacuation route sign during storm

Impact of Severe Weather Conditions on Biological Products

CBER is providing interested persons with information concerning the storage and use of temperature-sensitive biological products that have been involved in a temporary electrical power failure or flood conditions.

Learn More

Stay Connected

Follow CBER on Twitter

CBER's main goal for Twitter is to provide up-to-date information to consumers, health professionals, regulated industry and other interested stakeholders about CBER regulated products.

Workshops, Meetings & Conferences

FDA's Center for Biologics Evaluation and Research (CBER) sponsors or co-sponsors meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

Contact Us

Center for Biologics Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave WO71-3128
Silver Spring, MD 20993-0002

ocod@fda.hhs.gov

(800) 835-4709
(240) 402-8010

Hours Available

Food and Drug Administration
Food and Drug Administration
White Oak Campus

10903 New Hampshire Ave
Silver Spring, MD 20993
United States


Back to Top